Wellington Biomedical Innovation Master Investors (Cayman) II L.P. bought MTSR
January 30, 2025 · Form 4 insider transaction
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. bought 1,857,699 shares of MTSR, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,857,699
Price
N/A
Total value
N/A
Role10% owner
CompanyMTSR
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJanuary 30, 2025
Filing dateFebruary 3, 2025
Shares owned after1,857,699
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock automatically converted into Common Stock on a 2.349723-for-1 basis upon closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.